Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule precision medicines targeting renal, cardiovascular, metabolic diseases, and obesity. With its headquarters in South San Francisco, California, the company leverages cutting-edge genetic insights to drive its innovative therapeutic pipeline. As it advances its clinical programs, Maze aims to address significant unmet medical needs, positioning itself as a leader in the precision medicine landscape.